Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(18):1353; doi:10.1093/jnci/96.18.1353
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zielinski, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Sarah L. Zielinski

The first 10% of the full text of this article appears below.

Circulating Tumor Cell Levels May Predict Breast Cancer Prognosis

Patients with metastatic breast cancer who had five or more circulating tumor cells in a sample of their blood had shorter progression-free and overall survival times than patients with fewer circulating tumor cells, according to a new study.

In the August 19 issue of the New England Journal of Medicine, Massimo Cristofanilli, M.D., of the University . . . [Full Text of this Article]

Surveillance Colonoscopies Performed Too Often, Study Says

FDA, Genentech Warn of Heart Problems With Bevacizumab


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
J. D. Floyd, D. T. Nguyen, R. L. Lobins, Q. Bashir, D. C. Doll, and M. C. Perry
Cardiotoxicity of Cancer Therapy
J. Clin. Oncol., October 20, 2005; 23(30): 7685 - 7696.
[Abstract] [Full Text] [PDF]